Clinical Trial Update: Vernakalant Versus Ibutilide In Recent-Onset Atrial Fibrillation [Phase 4]

View source ↗

Summary

Phase 4 trial comparing vernakalant to ibutilide for recent-onset atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• CORVERT (ibutilide fumarate)
• Vernakalant (vernakalant)

Snippet

Sponsor: Medical University of Vienna | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED